Chemical Structure : dIRF4-2
货号: PC-27186Not For Human Use, Lab Use Only.
dIRF4-2 is a first-in-class, highly seletive proteolysis-targeting chimera (PROTAC) degrader of interferon regulatory factor 4 (IRF4) with DC50 of 2.3 µM and 2.2 µM for OPM2 and MM1.S, respectively (4h).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
dIRF4-2 is a first-in-class, highly seletive proteolysis-targeting chimera (PROTAC) degrader of interferon regulatory factor 4 (IRF4) with DC50 of 2.3 µM and 2.2 µM for OPM2 and MM1.S, respectively (4h).
dIRF4-2 shows rapid IRF4 depletion at 2 hours and as low as 1 µM concentrations in both MM1.S and OPM2 cell lines.
dIRF4-2 shows no neosubstrate degradation, dIRF4-2 can redirect CRBN to the nucleus to initiation degradation of IRF4, as measured by significant increases in Pearson correlation between IRF4 and CRBN.
dIRF4-2 phenocopies the effect of IRF4 loss, and is cytotoxic across IRF4-dependent MM cell models (IC50=700-800 nM).
| 分子量 | 786.89 | |
| 分子式 | C43H46N8O7 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Agius MP, et al. Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma. Nat Chem Biol. 2026 May 28.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright